These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 14688356)

  • 21. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells.
    Vultur A; Cao J; Arulanandam R; Turkson J; Jove R; Greer P; Craig A; Elliott B; Raptis L
    Oncogene; 2004 Apr; 23(15):2600-16. PubMed ID: 15007380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of JAK/STAT (Janus kinase/signal transducer and activator of transcription) in the thyrotropin signaling pathway.
    Park ES; Kim H; Suh JM; Park SJ; You SH; Chung HK; Lee KW; Kwon OY; Cho BY; Kim YK; Ro HK; Chung J; Shong M
    Mol Endocrinol; 2000 May; 14(5):662-70. PubMed ID: 10809230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling.
    Kamakura S; Oishi K; Yoshimatsu T; Nakafuku M; Masuyama N; Gotoh Y
    Nat Cell Biol; 2004 Jun; 6(6):547-54. PubMed ID: 15156153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells.
    Nosaka T; Kitamura T
    Int J Hematol; 2000 Jun; 71(4):309-19. PubMed ID: 10905049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes.
    McWhinney CD; Hunt RA; Conrad KM; Dostal DE; Baker KM
    J Mol Cell Cardiol; 1997 Sep; 29(9):2513-24. PubMed ID: 9299374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
    Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
    Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The functional role of the JAK-STAT pathway in post-infarction remodeling.
    El-Adawi H; Deng L; Tramontano A; Smith S; Mascareno E; Ganguly K; Castillo R; El-Sherif N
    Cardiovasc Res; 2003 Jan; 57(1):129-38. PubMed ID: 12504822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stat-1 is not essential for inhibition of B lymphopoiesis by type I IFNs.
    Gongora R; Stephan RP; Schreiber RD; Cooper MD
    J Immunol; 2000 Sep; 165(5):2362-6. PubMed ID: 10946258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RET-familial medullary thyroid carcinoma mutants Y791F and S891A activate a Src/JAK/STAT3 pathway, independent of glial cell line-derived neurotrophic factor.
    Plaza Menacho I; Koster R; van der Sloot AM; Quax WJ; Osinga J; van der Sluis T; Hollema H; Burzynski GM; Gimm O; Buys CH; Eggen BJ; Hofstra RM
    Cancer Res; 2005 Mar; 65(5):1729-37. PubMed ID: 15753368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of Janus kinase 2 by cisplatin in cancer cells.
    Song H; Sondak VK; Barber DL; Reid TJ; Lin J
    Int J Oncol; 2004 Apr; 24(4):1017-26. PubMed ID: 15010843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
    Flowers LO; Subramaniam PS; Johnson HM
    Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
    Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Jak-STAT pathway stimulated by interleukin 6.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr9. PubMed ID: 15561981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation.
    Bellido T; Borba VZ; Roberson P; Manolagas SC
    Endocrinology; 1997 Sep; 138(9):3666-76. PubMed ID: 9275051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
    Alas S; Bonavida B
    Clin Cancer Res; 2003 Jan; 9(1):316-26. PubMed ID: 12538484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
    Bright JJ; Sriram S
    J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor.
    Guo D; Dunbar JD; Yang CH; Pfeffer LM; Donner DB
    J Immunol; 1998 Mar; 160(6):2742-50. PubMed ID: 9510175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
    Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of JAK-STAT signaling pathway in cardiac remodeling].
    Wang HD; Lu DX; Huang QF
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):365-8. PubMed ID: 14992026
    [No Abstract]   [Full Text] [Related]  

  • 40. IL-6 up-regulates mcl-1 in human myeloma cells through JAK / STAT rather than ras / MAP kinase pathway.
    Puthier D; Bataille R; Amiot M
    Eur J Immunol; 1999 Dec; 29(12):3945-50. PubMed ID: 10602002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.